Tuesday, 8 September 2026European Markets

PROSAFE Stock Impressive Jump On Thursday, Outperforms Market

Loading stream...

(VIANEWS) - The Market ended the session with PROSAFE (PRS.OL) rising 18.82% to kr37.25 on Thursday, following the last session's downward trend. Oslo Børs Benchmark Index_GI rose 0.31% to kr1,428.10, after two sequential sessions in a row of losses, on what was a somewhat up trend trading session today.

PROSAFE's last close was kr31.35, 73.37% below its 52-week high of kr117.71.

About PROSAFE

Prosafe SE, together with its subsidiaries, owns and operates semi-submersible accommodation vessels in South America, north America, and Europe. It is also involved in the maintenance and modification of installations on fields for the production, hook-up and commissioning of new fields, tiebacks to existing infrastructure, and decommissioning activities. The company owns and operates a fleet of six semi-submersible accommodation vessels and one tender support vessel. It primarily serves oil and gas industries. Prosafe SE was founded in 1972 and is headquartered in Stavanger, Norway.

Earnings Per Share

As for profitability, PROSAFE has a trailing twelve months EPS of kr-42.06.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -261.72%.

More news about PROSAFE (PRS.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Investment Boom Meets Market Skepticism: Palantir's Contract Win vs. Stock Slide Amid Record Private AI Funding
Palantir secured the Army's high-profile TITAN AI-sensing contract and added a new executive, yet its stock fell 6% the same day — a sign that even marquee government AI wins no longer guarantee investor confidence. This tension plays out against a backdrop of surging private capital flooding into AI and AI-adjacent companies (Stability AI, Socure, Generalist AI, Emerald AI, and others), showing a bifurcated market: venture funding for AI remains red-hot while public-market sentiment toward AI-defense/enterprise plays is growing more cautious.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
General Motors Company
Both facts reference General Motors' cash position at the identical point in time (2025-12-31), both measuring FY 2025 period-end. Fact A reports $20.945 billion while Fact B reports $21.7 billion—a $755 million discrepancy (3.6% difference). Since they share the same entity, attribute, date, and fiscal period with conflicting values, this is a genuine contradiction, not a change over time. The difference is material enough to suggest either: different source data, different cash classifications (e.g., one includes equivalents/restricted cash), preliminary vs. final figures, or a data quality issue.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,278 source documents archived
Query this data → isubstrate.com